CYP3A4 Metabolism Before and After Surgery Induced Weight Loss Using Midazolam as Model Drug
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
Before and during bariatric surgery patients are given oral and i.v. midazolam, respectively
and blood samples are drawn to establish midazolam time-concentration profiles. After 0.5-2
years, and substantial weight loss, oral and i.v. midazolam are administered once more and
blood samples are taken again.